Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Chen, W
Title
Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors.
Citation
Communications biology; 2023 Apr 11; 6(1) pg393
PubMed ID
37041280
Show Usages
Product Cited
Cross-Reactivity
Applications
300-07
Human
in vitro
AF-200-03
Human
in vitro
100-64
Human
in vitro
100-11
Human
in vitro
First Author
Eernstman, J
Title
Novel variants in Krueppel like factor 1 that cause persistence of fetal hemoglobin in In(Lu) individuals
Citation
Scientific reports; 2021 Sep 17; 11(1) pg18557
PubMed ID
34535703
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-300-18
Human
in vitro
AF-200-03
Human
in vitro
AF-200-06
Human
in vitro
First Author
Thornton, N
Title
Disruption of the tumour-associated EMP3 enhances erythrid proliferation and causes the MAM-negative phenotype
Citation
Nature communications; 2020 Jul 16; 11(1) pg3569
PubMed ID
32678083
Show Usages
Product Cited
Cross-Reactivity
Applications
300-07
Human
in vitro
300-18
Human
in vitro
300-19
Human
in vitro
AF-200-03
Human
in vitro
First Author
Thomé, C H
Title
NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia
Citation
Scientific reports; 2020 Jun 25; 10(1) pg10315
PubMed ID
32587277
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-200-03
Human
in vitro
AF-300-23
Human
in vitro
AF-300-03
Human
in vitro
AF-300-07
Human
in vitro
First Author
Xu, R
Title
Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain
Citation
Nature communications; 2020 Mar 27; 11(1) pg1577
PubMed ID
32221280
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-100-20
Human
in vitro
AF-120-05ET
Human
in vitro
AF-200-03
Human
in vitro
First Author
Xu, Y
Title
TAF1 plays a critical role in AML1-ETO driven leukemogenesis.
Citation
Nature Communications;2019 10 29; 10(1) pg4925
PubMed ID
31664040
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-300-07
Human
in vitro
AF-300-19
Human
in vitro
AF-200-03
Human
in vitro
AF-200-06
Human
in vitro
AF-300-23
Human
in vitro
AF-300-03
Human
in vitro
First Author
Song, L
Title
Functionalization of Brain Region-specific Spheroids with Isogenic Microglia-like Cells.
Citation
Scientific Reports;2019 7 30; 9(1) pg11055
PubMed ID
31363137
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-100-20
Human
in vitro
AF-120-05ET
Human
in vitro
AF-300-07
Human
in vitro
AF-300-19
Human
in vitro
AF-200-03
Human
in vitro
AF-300-03
Human
in vitro
First Author
Pavel-Dinu, M
Title
Gene correction for SCID-X1 in long-term hematopoietic stem cells.
Citation
Nature Communications;2019 4 9; 10(1) pg1634
PubMed ID
30967552
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-200-02
Human
in vitro
AF-300-07
Human
in vitro
AF-300-19
Human
in vitro
200-07
Human
in vitro
AF-200-03
Human
in vitro
AF-300-03
Human
in vitro
AF-300-18
Human
in vitro
100-64
Human
in vitro
AF-200-15
Human
in vitro
200-06
Human
in vitro
First Author
Trump, L
Title
Neutrophils Derived from Genetically Modified Human Induced Pluripotent Stem Cells Circulate and Phagocytose Bacteria In Vivo.
Citation
Stem Cells Translational Medicine;2019 6 1; 8(6) pg557-567
PubMed ID
30793529
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-300-07
Human
in vitro
AF-300-18
Human
in vitro
AF-200-03
Human
in vitro
AF-200-06
Human
in vitro
AF-300-19
Human
in vitro
AF-300-03
Human
in vitro
AF-100-18B
Human
in vitro
First Author
Río, P
Title
Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34
Citation
Blood; 2017 Sep 28; 130(13) pg1535-1542
PubMed ID
28801449
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-300-07
Human
in vitro
AF-300-18
Human
in vitro
AF-300-19
Human
in vitro
AF-200-03
Human
in vitro
showing 10 of 44
Show More